
18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy
Author(s) -
Devan Diwanji,
Kimberly M. Ray,
Nola M. Hylton
Publication year - 2021
Publication title -
radiology. imaging cancer
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2638-616X
DOI - 10.1148/rycan.2021219021
Subject(s) - medicine , pertuzumab , trastuzumab , neoadjuvant therapy , breast cancer , oncology , chemotherapy , positron emission tomography , biomarker , fluorodeoxyglucose , cancer , radiology , biochemistry , chemistry